Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes

35Citations
Citations of this article
102Readers
Mendeley users who have this article in their library.

Abstract

The lymphatic system plays an indispensable role in humoral balance, lipid metabolism, and immune regulation. The lymph nodes (LNs) are known as the primary sites of tumor metastasis and the metastatic LNs largely affected the prognosis of the patiens. A well-designed lymphatic-targeted system favors disease treatment as well as vaccination efficacy. In recent years, development of nanotechnologies and emerging biomaterials have gained increasing attention in developing lymph-node-targeted drug-delivery systems. By mimicking the endogenous macromolecules or lipid conjugates, lymph-node-targeted nanocarries hold potential for disease diagnosis and tumor therapy. This review gives an introduction to the physiological functions of LNs and the roles of LNs in diseases, followed by a review of typical lymph-node-targeted nanomaterial-based drug-delivery systems (e.g., liposomes, micelles, inorganic nanomaterials, hydrogel, and nanocapsules). Future perspectives and conclusions concerned with lymph-node-targeted drug-delivery systems are also provided.

Cite

CITATION STYLE

APA

Cheng, Z., Que, H., Chen, L., Sun, Q., & Wei, X. (2022, July 1). Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes. Pharmaceutics. MDPI. https://doi.org/10.3390/pharmaceutics14071372

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free